# MANE (Veradermics, Inc) - SEC EDGAR Financial Statements

> Veradermics, Inc reported $807.2M in total assets and a net loss of $93.58M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/MANE
- Markdown: https://convexityos.com/fundamentals/MANE.md
- SEC CIK: 0001827635
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:14 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001827635&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$111.2M | Operating profit |
| Net Income | FY 2025 | -$93.58M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.22 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$82.60M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $798.4M | Total debt: $371K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Research & Development | $62.06M | $23.28M |
| Total Operating Expenses | $72.35M | $26.78M |
| **Operating Income** | -$72.35M | -$26.78M |
| Interest Income | $1.56M | $481K |
| Interest Expense | $0 | $585K |
| Income Before Tax | -$70.00M | -$26.49M |
| Income Tax Expense | $0 | $0 |
| **Net Income** | -$70.00M | -$26.49M |
| Basic EPS | -$1,119.10 | -$370.50 |
| **Diluted EPS** | -$1,119.10 | -$370.50 |
| Basic Shares Outstanding | 74.5K | 73.7K |
| Diluted Shares Outstanding | 74.5K | 73.7K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $16.07M | $18.61M | $20.93M | $18.19M | $18.10M | $14.33M | $11.45M |
| Total Operating Expenses | $28.78M | $29.55M | $29.86M | $23.01M | $20.35M | $16.07M | $12.91M |
| **Operating Income** | -$28.78M | -$29.55M | -$29.86M | -$23.01M | -$20.35M | -$16.07M | -$12.91M |
| Interest Income | $5.10M | $4.84M | $2.48M | $906K | $71K | $103K | $482K |
| Income Before Tax | -$21.00M | -$23.50M | -$27.23M | -$21.85M | -$20.10M | -$15.64M | -$12.40M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$21.00M | -$23.50M | -$27.23M | -$21.85M | -$20.10M | -$15.64M | -$12.40M |
| Basic EPS | -$0.50 | -$0.58 | -$1.32 | -- | -$30.15 | -$24.19 | -$19.79 |
| **Diluted EPS** | -$0.50 | -$0.58 | -$1.32 | -- | -$30.15 | -$24.19 | -$19.79 |
| Basic Shares Outstanding | 42.1M | 40.4M | 22.7M | -- | 748.5K | 744.6K | 736.9K |
| Diluted Shares Outstanding | 42.1M | 40.4M | 22.7M | -- | 748.5K | 744.6K | 736.9K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $21.77M | $53.08M |
| Short-Term Investments | $120.1M | $0 |
| **Cash & Short-Term Investments** | $141.9M | $53.08M |
| Other Current Assets | $307K | $38K |
| **Total Current Assets** | $152.5M | $55.53M |
| Property, Plant & Equipment, Net | $22K | $0 |
| **Total Non-Current Assets** | $125K | $0 |
| **Total Assets** | $152.6M | $55.53M |
| Accounts Payable | $2.13M | $2.25M |
| Other Current Liabilities | $47K | $0 |
| **Total Current Liabilities** | $9.15M | $4.72M |
| **Total Non-Current Liabilities** | $4.0K | $0 |
| **Total Liabilities** | $9.16M | $4.72M |
| **Total Debt (incl. Leases)** | $4.0K | -- |
| Common Stock | $1.0K | $1.0K |
| Retained Earnings | -$123.4M | -$49.23M |
| Accumulated Other Comp. Income | $60K | $0 |
| **Total Stockholders' Equity** | -$121.0M | -$48.48M |
| Total Equity | -$121.0M | -$48.48M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $132.2M | $319.3M | $168.4M | $21.77M | $53.08M |
| Short-Term Investments | $666.2M | $500.6M | $222.4M | $120.1M | $0 |
| **Cash & Short-Term Investments** | $798.4M | $819.9M | $390.8M | $141.9M | $53.08M |
| Other Current Assets | -- | -- | $602K | $307K | $38K |
| **Total Current Assets** | $805.8M | $824.7M | $397.1M | $152.5M | $55.53M |
| Property, Plant & Equipment, Net | $386K | $41K | $21K | $22K | $0 |
| **Total Non-Current Assets** | $1.43M | $989K | $287K | $125K | $0 |
| **Total Assets** | $807.2M | $825.7M | $397.4M | $152.6M | $55.53M |
| Accounts Payable | $1.91M | $5.92M | $1.07M | $2.13M | $2.25M |
| Other Current Liabilities | $297K | $379K | $39K | $47K | $0 |
| **Total Current Liabilities** | $10.37M | $11.69M | $6.72M | $9.15M | $4.72M |
| **Total Non-Current Liabilities** | $371K | $428K | $0 | $4.0K | $0 |
| **Total Liabilities** | $10.74M | $12.12M | $6.72M | $9.16M | $4.72M |
| **Total Debt (incl. Leases)** | $371K | $428K | -- | $4.0K | -- |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$195.2M | -$174.2M | -$150.7M | -$123.4M | -$49.23M |
| Accumulated Other Comp. Income | -$3.05M | -$895K | -$524K | $60K | $0 |
| **Total Stockholders' Equity** | $796.5M | $813.6M | $390.6M | -$121.0M | -$48.48M |
| Total Equity | $796.5M | $813.6M | $390.6M | -$121.0M | -$48.48M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Net Income | -$70.00M | -$26.49M |
| Stock-Based Compensation | $1.44M | $250K |
| Change in Payables | -$122K | $646K |
| **Operating Cash Flow** | -$71.60M | -$23.69M |
| Capital Expenditure | -$24K | $0 |
| **Free Cash Flow** | -$71.63M | -$23.69M |
| Purchases of Investments | -$143.9M | $0 |
| **Investing Cash Flow** | -$118.9M | $0 |
| **Financing Cash Flow** | $159.1M | $60.48M |
| **Net Change in Cash** | -$31.32M | $36.79M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$21.00M | -$23.50M | -$27.23M | -$21.85M | -$20.10M | -$15.64M | -$12.40M |
| Stock-Based Compensation | $4.09M | $3.52M | $5.26M | $974K | $138K | $115K | $213K |
| Change in Payables | -$4.01M | $4.85M | -$1.05M | $141K | $1.45M | -$1.03M | -$686K |
| **Operating Cash Flow** | -$22.95M | -$14.49M | -$21.17M | -$23.63M | -$19.01M | -$15.64M | -$13.32M |
| Capital Expenditure | -$346K | -$21K | $0 | -$5.0K | $0 | $0 | -$19K |
| **Free Cash Flow** | -$23.29M | -$14.51M | -$21.17M | -$23.63M | -$19.01M | -$15.64M | -$13.34M |
| Purchases of Investments | -$209.8M | -$305.6M | -$123.0M | -$119.8M | $0 | -$8.33M | -$15.73M |
| **Investing Cash Flow** | -$165.6M | -$277.3M | -$101.3M | -$109.8M | $15.00M | -$8.33M | -$15.75M |
| **Financing Cash Flow** | $1.33M | $442.7M | $269.1M | $149.5M | $1.08M | $129K | $8.42M |
| **Net Change in Cash** | -$187.2M | $150.9M | $146.6M | $16.11M | -$2.94M | -$23.84M | -$20.64M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Return on Assets (ROA) | -45.9% | -47.7% |
| Current Ratio | 16.66x | 11.77x |
| Quick Ratio | 15.50x | 11.25x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -11.7% | -11.4% | -21.7% | -- | -- | -- | -- |
| Return on Assets (ROA) | -11.6% | -11.2% | -21.3% | -45.9% | -- | -- | -- |
| Current Ratio | 77.68x | 70.53x | 59.12x | 16.66x | -- | -- | -- |
| Quick Ratio | 76.97x | 70.11x | 58.19x | 15.50x | -- | -- | -- |
| Debt to Equity | 0.00x | 0.00x | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
